Skip to main content
Back to News

News From Around the System

Promising Parkinson’s therapy gets FDA investigational nod

UCI Health — June 5, 2024

Orange, Calif. — The promising investigational cell therapy bemdaneprocel for the treatment of Parkinson’s disease has been granted Regenerative Medicine Advanced Therapy (RMAT) designation by the U.S. Food and Drug Administration (FDA). RMAT-designated therapies are eligible for expedited review, guidance and a path to accelerated approval. UCI Medical Center was…

Climate change is making our allergies worse, says UCI Health immunologist

UCI Health — June 4, 2024

IN THE NEWS: Springtime means flowers, birds and the inevitable seasonal allergies. But things are changing. Allergy, asthma and immunology specialists from around the country are seeing a growing number of patients experiencing allergies that have become more severe. On top of that, allergies appear to be getting less seasonal…

UC San Diego Health First in Region to Provide Novel Therapy for Melanoma

UC San Diego Health — June 4, 2024

UC San Diego Health is the first hospital system in the region to offer a new immunotherapy treatment for metastatic melanoma. The personalized cellular therapy derived from tumor infiltrating lymphocytes (TIL), is the first solid tumor therapy on the market approved by the U.S. Food and Drug...

Health Media Contacts

Find the best contact for health-related media inquiries.

View All Media Contacts